Andrew Young

Title: The Innovative Contributions of Andrew Young

Introduction

Andrew Young is a notable inventor based in Cleveland, OH (US). He has made significant contributions to the field of medical diagnostics, particularly in cancer detection. With a total of 2 patents, his work focuses on innovative methods that enhance the understanding and diagnosis of cancer risks.

Latest Patents

One of Andrew Young's latest patents is titled "Biomarkers for human monocyte myeloid-derived suppressor cells." This method involves diagnosing an increased risk of cancer by obtaining a blood sample and determining the levels of specific polypeptides. An increase in the levels of these polypeptides compared to a control level indicates a heightened risk of cancer in the subject.

Another significant patent is related to "Methods of detecting cancer." This method aims to detect the presence of glioblastomas and recurrent glioblastomas by isolating CD14+ cells from a blood sample. The ratio of isolated CD14+ cells expressing low levels of HLA-DR to those expressing VNN2 is analyzed, with a higher ratio indicating an increased risk of glioblastomas.

Career Highlights

Andrew Young is affiliated with Case Western Reserve University, where he continues to advance his research in cancer diagnostics. His work is pivotal in developing methods that could potentially save lives through early detection of cancer.

Collaborations

He collaborates with esteemed colleagues such as Kevin D Cooper and Thomas S McCormick, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Andrew Young's contributions to cancer diagnostics through his innovative patents highlight the importance of research in improving medical outcomes. His work exemplifies the impact of dedicated inventors in the field of healthcare.